Results 241 to 250 of about 133,829 (277)

Polymorph‐Specific Electronic Transduction in WO3 during Molecular Sensing

Advanced Materials, EarlyView.
Metal‐oxide polymorphs with similar surface chemistry can nevertheless exhibit distinct sensing properties. In γ‐ and ε‐WO3, analyte adsorption appears comparable; yet, only ε‐WO3 induces a pronounced lattice electronic perturbation that accommodates charge in sub‐conduction band minimum states.
Matteo D'Andria, Meng Yin, Stefan Neuhauser, Vlasis G. Mavrantzas, Ying Chen, Ken Suzuki, Andreas T. Güntner   +6 more
wiley   +1 more source

A comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer. [PDF]

Sci Rep
Mugundan UM, Saravanan V, Ganesan RM.
europepmc   +1 more source

Lattice‐Matched 2D Template Enables Efficient Cesium Tin Halide Perovskite Solar Cells

Advanced Materials, EarlyView.
Lattice‐matched 2D perovskite PEA2CsSn2I7 templates the out‐of‐plane growth of inorganic 3D γ‐CsSnI3 along the (110) plane, forming highly oriented 2D/3D tin halide perovskite heterostructures. With reduced trap states and mitigated δ‐phase impurities, the CsSnI3‐based solar cells achieve a power conversion efficiency of 15.27% and maintain stable ...
Hongzhe Anna Xu, Dongxu He, Wencai Zhou, Julian A. Steele, Zhiliang Wang, Zitong Wang, Chengxi Zhang, Shanshan Ding, Bowei Zhang, Huiyuan Cheng, Mengmeng Hao, Jiangyu Hang, Can Zheng, Zilong Zheng, Peng Chen, Lianzhou Wang   +15 more
wiley   +1 more source

Computational analysis of umami and bitter taste interactions: orthogonality in receptor-ligand binding. [PDF]

RSC Adv
Shityakov S, Afolabi SO, Ashikhmina MS, Skorb EV, Nosonovsky M.   +4 more
europepmc   +1 more source

Osteoprotegerin, rank and rank ligand [PDF]

, 2007
The discovery of the osteoprotegerin, receptor activator of nuclear factor-kappa B ligand and receptor activator of nuclear factor-kappa B and identification of their role in osteoclastogenesis provided a major advance in bone biology. receptor activator of nuclear factor-kappa B ligand binds to its receptors on the surface of preosteoclasts and ...
Kurban, Sevil, Mehmetoglu, Idris
core   +4 more sources

Expression of RANK‐ligand in prostate cancer cell lines [PDF]

Scandinavian Journal of Clinical and Laboratory Investigation, 2009
The molecular mediators of bone remodelling, receptor activator of nuclear factor-kappaB ligand (RANKL), receptor activator of nuclear factor-kappaB (RANK) and osteoprotegerine (OPG), are believed to be involved in the cellular mechanisms by which tumours metastasize to bone. RANKL is a potent stimulator of osteoclastic bone resorption and is expressed
Hendrik, Penno, Olle, Nilsson, Helena, Brändström, Ola, Winqvist, Osten, Ljunggren   +4 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Ranking the role of RANK ligand in apoptosis

Apoptosis, 2004
Many members of tumor necrosis factor (TNF) superfamily are characterized by their ability to induce apoptosis once they bind in a homotrimeric manner to their cognate receptors. The receptor activator of nuclear factor-kappaB ligand (RANKL), a member of the TNF superfamily identified seven years ago, was originally described as a factor that induced ...
A C, Bharti, B B, Aggarwal
openaire   +2 more sources

Osteoprotegerin and rank ligand expression in prostate cancer

Urology, 2001
To investigate the expression of osteoprotegerin (OPG) and RANK ligand (RANKL) in human prostatic tissues. The factors regulating the increased turnover associated with prostate cancer (CaP) bone metastasis are unknown. OPG and RANKL are recently identified regulators of bone resorption and bone remodeling.Tissues from 28 patients with CaP and from 4 ...
J M, Brown, E, Corey, Z D, Lee, L D, True, T J, Yun, M, Tondravi, R L, Vessella   +6 more
openaire   +2 more sources

RANK ligand and osteoprotegerin in myeloma bone disease

Blood, 2003
Myeloma bone disease is due to interactions of myeloma cells with the bone marrow microenvironment, and is associated with pathologic fractures, neurologic symptoms and hypercalcemia. Adjacent to myeloma cells, the formation and activation of osteoclasts is increased, which results in enhanced bone resorption.
Orhan, Sezer, Ulrike, Heider, Ivana, Zavrski, Christian Alexander, Kühne, Lorenz Christian, Hofbauer   +4 more
openaire   +2 more sources

Clinical applications of RANK‐ligand inhibition

Internal Medicine Journal, 2009
AbstractAn enhanced rate of bone remodelling fuelled by osteoclastogenesis mediates diseases such as osteoporosis, arthritic bone destruction, Paget’s disease and malignancy‐induced bone loss. Thus, the control of osteoclastogenesis is of major clinical importance.
openaire   +2 more sources